ACC President Christopher Kramer, MD, testified before a Congressional subcommittee to ask for federal funding to support a new law aimed at reducing sudden cardiac arrest deaths, and to support NIH research.
Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.
Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of…
Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.
With both new and revised measures, the document’s authors aim to provide clinicians usable advice in a digestible format.
Matthew Budoff, MD, detailed new data highlighting CCTA’s value when it comes to tracking the progression of coronary atherosclerosis.
As time goes on, the gaps between the healthiest states and the least healthy states are only getting wider and wider. “Our findings highlight the…
Matthew Budoff, MD, detailed new data highlighting CCTA’s value when it comes to tracking the progression of coronary atherosclerosis.
Contact: Ju lie Boyland, jboyland@acc.org , A new study puts the spotlight on the rising burden of ischemic heart disease across Southeast Asia, East Asia…
Contact: Julie Boyland, jboyland@acc.org, Intermountain Health cardiovascular clinician and researcher Viet Le, DMSc, MPAS, PA-C, FACC, will serve as the next editor of the American…
This two-year analysis of the FISH&CHIPS study found that using advanced AI from Heartflow to evaluate cardiac CT is safe, effective and limits the use…
